<DOC>
	<DOCNO>NCT02408965</DOCNO>
	<brief_summary>Excessive bleeding dilation evacuation ( D &amp; E ) require intervention common , occur approximately 30 % case one large abortion-providing clinic . Uterotonic prophylaxis time D &amp; E , particularly methylergonovine maleate ( MM ) , common practice among D &amp; E provider despite nearly evidence efficacy . Finding way decrease excessive bleeding D &amp; E potential improve patient safety reduce cost provider-initiated intervention . The investigator propose randomize , control trial investigate efficacy MM prophylaxis versus placebo decrease excessive bleeding measure composite outcome among woman undergo D &amp; E 20 24 week .</brief_summary>
	<brief_title>Uterotonic Prophylaxis Trial</brief_title>
	<detailed_description />
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Methylergonovine</mesh_term>
	<criteria>Between 20 wks 0 day gestation 24 wks 0 day gestation English Spanish speaking BP injection 140/90 18 year old</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>